Express News | Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

BreakingsDec 19 20:00

Press Release: Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

Dow JonesDec 19 20:00

Express News | Lexeo Therapeutics Inc Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

BreakingsDec 13 21:20

Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics

Yahoo FinanceNov 28 18:18

Baird Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $28

Futu NewsNov 21 15:31 · Ratings

Lexeo Therapeutics' Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity

TipRanksNov 21 14:36